Today's After-Hours Movers:Novavax, Inc., (Nasdaq: NVAX) 83% LOWER; announced topline data from two clinical trials of its RSV F-protein recombinant ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Special Reports

Canaccord Genuity Raises Price Target on Intel (INTC) After Meeting with Management September 20, 2016 11:44 AM Brean Capital Raises Price Target as Intel (INTC) Updates Revenue Guidance September 20, 2016 9:40 AM Nomura Securities Raises Price Target on Intel (INTC) to $42 September 19, 2016 9:16 AM UBS Raises Price Target on Intel (INTC) to $43 Ahead of 3Q Report September 19, 2016 8:46 AM Mizuho Securities Raises Price Target on Intel (INTC) to $42; Reiterates Buy September 19, 2016 8:22 AM FBR Capital Reiterates Outperform as Pandora (P) Announces Warner Music Deal September 16, 2016 11:08 AM